상세 보기
Recurrent Coronary Artery Vasospasm in a Patient with Hepatocellular Carcinoma Treated with Sorafenib: a Case Report and Literature Review
- Lim, Dae Hyun;
- Yoon, Jai Hoon;
- Jun, Dae Won;
- Lee, Oh Young;
- Yoon, Byung Chul;
- 외 3명
Citations
SCOPUS
1초록
Tyrosine kinase inhibitors are widely used as targeted treatments for various malignancies. Sorafenib is an orally active tyrosine kinase inhibitor that blocks the signaling pathways of several growth factors. Its use is approved for various malignancies such as unresectable hepatocellular carcinoma, renal cell carcinoma, and gastrointestinal stromal tumors. Several adverse effects have been reported in the literature; however, cardiotoxicity is rare. We present a case of recurrent coronary vasospasm caused by short-term administration (5 days) of sorafenib. Since it caused refractory ischemia after re-administration, we had no choice but to stop the treatment.
키워드
Sorafenib; Coronary artery vasospasm; Variant angina; Tyrosine kinase inhibitor; Vascular endothelial growth factor inhibitor
- 제목
- Recurrent Coronary Artery Vasospasm in a Patient with Hepatocellular Carcinoma Treated with Sorafenib: a Case Report and Literature Review
- 저자
- Lim, Dae Hyun; Yoon, Jai Hoon; Jun, Dae Won; Lee, Oh Young; Yoon, Byung Chul; Lee, Hang Rak; Kim, Kyung Soo; Choi, Ho Soon
- 발행일
- 2020-03
- 저널명
- 대한간암학회지
- 권
- 20
- 호
- 1
- 페이지
- 67 ~ 71